---
$id: https://graph.org.ai/products/commodity/51162641
$type: Product
source: UNSPSC
code: "51162641"
title: "Oxeladin"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oxeladin

**UNSPSC Code**: 51162641
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C20H33NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) SNC1080T5Y, chemically known as 2-(2-diethylaminoethoxy)ethyl alpha,alpha-diethylphenylacetate but more generally known as oxeladin, which bears US NIH Compound Identifier 4619. European Medicines Agency schedules Oxeladin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09513MIG. World Health Organization schedules oxeladin in its Anatomical Therapeutic Chemical (ATC) Classification. OXELADIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule oxeladin under HS 29221980 and SITC 51461. As of Q4 2014, OXELADIN remains US FDA's Preferred Term for this commodity. SMILES: O(C(=O)C(CC)(CC)C1CCCCC1)CCOCCN(CC)CC.

